Kyoto, Japan

Takashi Shimada

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Tsukuba, JP (2016)
  • Kyoto, JP (2012 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Takashi Shimada: Innovator in Monoclonal Antibody Detection

Introduction

Takashi Shimada is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of analytical techniques, particularly in the detection of monoclonal antibodies. With a total of 12 patents to his name, his work has advanced the methodologies used in biochemical analysis.

Latest Patents

One of his latest patents is a "Kit for preparing sample for detecting monoclonal antibody." This innovative sample preparation kit provides a versatile analytical technique that is unaffected by the diversity of antibodies, species differences, and various matrices. The kit includes a porous body for immobilizing the monoclonal antibody, nanoparticles with an immobilized protease, a reaction vessel for selective digestion, a buffer for the reaction, and a filtration membrane for extracting the reaction product.

Another notable patent is the "Method for improving result monoclonal antibody detection." This method involves capturing and immobilizing the monoclonal antibody in a porous body, conducting selective protease digestion, and detecting peptide fragments through liquid chromatography-mass spectrometry (LC-MS). This invention enhances the applicability of detection methods for monoclonal antibodies using mass spectrometry.

Career Highlights

Throughout his career, Takashi Shimada has worked with esteemed organizations such as Shimadzu Corporation and Keio University. His experience in these institutions has allowed him to develop and refine his innovative techniques in the field of antibody detection.

Collaborations

Takashi has collaborated with notable colleagues, including Noriko Iwamoto and Taka-Aki Sato. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Takashi Shimada's contributions to the field of monoclonal antibody detection are invaluable. His innovative patents and collaborations have paved the way for advancements in analytical techniques, making significant impacts in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…